Results 21 to 30 of about 29,702 (243)

Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation. [PDF]

open access: yesPLoS ONE, 2012
Mifepristone (RU486), a potent antagonist of progesterone and glucocorticoids, is involved in immune regulation. Our previous studies demonstrated that mifepristone directly augments the cytotoxicity of human uterine natural killer (uNK) cells.
Yuezhou Chen   +4 more
doaj   +1 more source

Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2023
Background Mifepristone, also known as RU-486, is an anti-progestational steroid with similar chemical structure to anabolic steroids. Given as a single dose in conjunction with misoprostol, mifepristone is used to induce medical abortion.
Taylor A. Ault   +4 more
doaj   +1 more source

Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment

open access: yesInternational Journal of Environmental Research and Public Health, 2021
Interstitial pregnancy is defined as the presence of a gestational sac in the most proximal section of the fallopian tube. Management of interstitial pregnancy remains a debated topic.
G. Stabile   +6 more
semanticscholar   +1 more source

Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. [PDF]

open access: yes, 2020
BackgroundEarly pregnancy loss is a common event in the first trimester, occurring in 15%-20% of confirmed pregnancies. A common evidence-based medical regimen for early pregnancy loss uses misoprostol, a prostaglandin E1 analog, with a dosage of 800 μg,
Atrio, Jessica M   +6 more
core   +1 more source

Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation

open access: yesObstetrics and Gynecology, 2021
The sequential use of mifepristone and misoprostol for termination of pregnancy after fetal death between 14 and 28 weeks of gestation reduces time to delivery compared with misoprostol alone.
E. Allanson   +7 more
semanticscholar   +1 more source

Medication Abortion With Pharmacist Dispensing of Mifepristone

open access: yesObstetrics and Gynecology, 2021
Medication abortion with pharmacist-dispensed mifepristone is effective, with a low prevalence of adverse events, and patients are satisfied with the model of care.
D. Grossman   +12 more
semanticscholar   +1 more source

US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.

open access: yesContraception, 2021
OBJECTIVE Protocols including mifepristone are the most effective medication regimens for medication abortion and early pregnancy loss (EPL) management. Both can be safely and effectively offered in primary care settings. Despite mifepristone's excellent
S. Srinivasulu   +5 more
semanticscholar   +1 more source

Mifepristone Directly Disrupts Mouse Embryonic Development in Terms of Cellular Proliferation and Maturation In Vitro

open access: yesToxics, 2021
Mifepristone (RU-486), a synthetic steroid with potent antiprogestogen and anti-glucocorticoid properties, has been widely used in clinical practice. Its effect on the endometrium, ovary, and fallopian tube has been well reported in many human and animal
Yu-Ting Su   +5 more
doaj   +1 more source

Mifepristone improves adipose tissue insulin sensitivity in insulin resistant individuals.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2021
BACKGROUND Increased tissue cortisol availability has been implicated in abnormal glucose and fat metabolism in patients with obesity, metabolic syndrome, and type 2 diabetes (T2DM).
Sriram Gubbi   +5 more
semanticscholar   +1 more source

The effects of mifepristone on the structure of human decidua and chorion and Bax and Bcl-2 expression at early stage of pregnancy

open access: yesBMC Pharmacology and Toxicology, 2022
Background As a progesterone receptor antagonist, mifepristone combined with misoprostol is widely used to terminate early pregnancy in clinical practice.
Fei Tian   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy